Business
Lattice Biologics Ltd. Appoints Chief Operating Officer
Lattice Biologics Ltd. Appoints Chief Operating Officer.
About this update from Lattice Biologics Ltd
[{"type":"text","content":"\nLattice Biologics Ltd. Appoints Chief Operating Officer\n\nLattice Biologics Ltd. Appoints Chief Operating Officer\n\n SCOTTSDALE, AZ--(Marketwired - May 31, 2017) - Lattice Biologics Ltd. (TSX VENTURE: LBL) (OTCQB: LBLTF) (the \"Company\") is pleased to announce the appointment of Darrel Holmes as Chief Operating Officer of the Company, effective May 30, 2017.Mr. Holmes is a seasoned executive with over 30 years of experience in the medical device manufacturing and tissue banking industries. Mr. Holmes brings a focus on operations management, regulatory and quality assurance, product development and overseeing corporate profitability.\"We are pleased to welcome Darrel to the executive team, where his extensive knowledge of biologics and manufacturing practices will help drive value for the Company,\" said Guy Cook, Lattice's Chief Executive Officer. \"Darrel is uniquely suited to help drive sales in our core products, and to accelerate the production of our Extracellular Matrix directed scaffold technology used in cancer diagnostics.\"\"I am very pleased to be joining Lattice Biologics at this exciting juncture in the Company's growth,\" commented Mr. Holmes. \"I look forward to working with the team to help the Company achieve its full potential.\" Lattice Biologics Ltd.Guy Cook,Chief Executive OfficerTelephone No: (480) 563-0800About Lattice Biologics Ltd.:Lattice Biologics Ltd. is an emerging precision medicine leader in the field of cellular therapies and tissue engineering, with an emphasis on bone, skin, and cartilage regeneration. As a manufacturer of the highest quality allografts, Lattice is focused on next generation products to improve surgical outcomes. Versatile allografts for a variety of surgical applications:Enhancing fusion in spine surgeryEnhancing breast reconstruction post mastectomy for breast cancer patientsSports medicine indications, including ACL repairPromotion of bone regeneration in foot and ankle surgeryPromotion of cranial healing following neurosurgeryEnhancing wound repair in burn victimsSubchondral bone defect repair in knee and other joint surgeriesThe Company is currently exploring new technologies in regenerative and personalized medicine: All natural amniotic fluid supplement for arthritic joints Demonstrates lasting pain relief and improved outcomes Personalized Cancer Diagnostics - revol...